Bright Green Corporation
BGXX39
$0.04arrow_drop_up14.05%$0.00
Penny Stock
BGXX39
$0.04
arrow_drop_up14.05%Performance History
| Key Stats | |
|---|---|
| Open | $0.04 |
| Prev. Close | $0.03 |
| EPS | -0.05 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| Market Cap | $15.29M |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 0.04 | 0.04 |
| 52 Week Range | 0.03 | 0.54 |
| Ratios | |
|---|---|
| Revenue | - |
| EBITDA Margin % | - |
| EPS | -0.05 |
Score Breakdown
Welcome to Stocklytics
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Analyst Forecast
Period: Next 12 Months
•Analyst Ratings
••
About Bright Green Corporation (BGXX)
- Sector
- Healthcare
- Industry
- Drug Manufacturers—Specialty & Generic
- CEO
- Headquarters
- Grants
- Employees
- 23
- Exchange
- NASDAQ
Keep an eye on Bright Green Corporation
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
What is Bright Green Corporation (BGXX) stock price performance year to date (YTD)?
As of the latest data, Bright Green Corporation (BGXX) has a year-to-date price change of -87.12%. Over the past month, the stock has experienced a price change of -78.36%. Over the last three months, the change has been -82.19%. Over the past six months, the figure is -81.49%.
help
What is Bright Green Corporation's (BGXX) price per share?
The current price per share for Bright Green Corporation (BGXX) is $0.04. The stock has seen a price change of $0.01 recently, indicating a 14.05% change. This reflects the stock's recent market performance and investor sentiment.
help
What is the 52-week high and low for Bright Green Corporation (BGXX)?
For Bright Green Corporation (BGXX), the 52-week high is $0.54, which is 1.18K% from the current price. The 52-week low is $0.03, the current price is 25.97% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.
help
Is Bright Green Corporation (BGXX) a growth stock?
Bright Green Corporation (BGXX) has shown an average price growth of -6.65% over the past three years. It has received a score of -2 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying Bright Green Corporation as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.
help
Is Bright Green Corporation (BGXX) a profitable company?
Bright Green Corporation (BGXX) has a net income of -$13.13M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of 0% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at , with a revenue growth rate of 97.24%, providing insight into the company's sales performance and growth. Operating income is noted at -$8.89M. Furthermore, the EBITDA is -$6.08M.
help
What is the market capitalization of Bright Green Corporation (BGXX)?
Bright Green Corporation (BGXX) has a market capitalization of $15.29M. The average daily trading volume is 588.52K, indicating the stock's liquidity and investor engagement.
News
PLANT-BASED API
PSYCHEDELICS
CANNABINOIDS
PHARMACEUTICAL INDUSTRY
NATURAL MEDICINE
THERAPEUTIC POTENTIAL
Plant-Based API Market Poised To Hit $52 Billion By 2034, Driven By Psychedelics And Cannabinoids
CANNABIS
DELISTING
STOCK EXCHANGES
FINANCIAL CHALLENGES
REVERSE STOCK SPLIT
RESTRUCTURING
Cannabis Companies Delisted From Major Stock Exchanges In 2024: What Went Wrong?
BRIGHT GREEN CORPORATION
NASDAQ
EB-5 CAPITAL RAISE PROGRAM
STRATEGIC PARTNERSHIPS
ACQUISITIONS
Bright Green Corporation Provides an Update, Reinforces Commitment to Shareholders, and Focuses on Growth and Strategic Partnerships
BRIGHT GREEN CORPORATION
BENUVIA OPERATIONS
PHARMACEUTICAL
CANNABINOIDS
PSYCHEDELICS
RAW MATERIALS
BRIGHT GREEN EMBARKS ON MAJOR PARTNERSHIP WITH BENUVIA OPERATIONS, LLC. WILL SUPPLY PHARMA EXPERT WITH AMERICAN MADE RAW MATERIALS FROM ITS INDUSTRY LEADING AND DEA-APPROVED SCH I & II DRUG FACILITY.
ALKYL KETENE DIMER
PAPER INDUSTRY
PACKAGING INDUSTRY
MARKET GROWTH
MARKET CHALLENGES
Global Alkyl Ketene Dimer Market Size To Worth USD 524.4 Million By 2033 | CAGR of 4.66% - GlobeNewswire
PRESS RELEASES
CEO UPDATE